Related Experiment Video

Updated: Feb 9, 2026

In Vitro Generation of Somite Derivatives from Human Induced Pluripotent Stem Cells
06:21

In Vitro Generation of Somite Derivatives from Human Induced Pluripotent Stem Cells

Published on: April 25, 2019

9.9K

The Application of Induced Pluripotent Stem Cells in Cardiac Disease Modeling and Drug Testing

Lingqun Ye1, Xuan Ni1, Zhen-Ao Zhao1,2

  • 1Institute for Cardiovascular Science & Department of Cardiovascular Surgery of First Affiliated Hospital, Medical College, Soochow University, Suzhou, 215000, China.

Journal of Cardiovascular Translational Research
|May 31, 2018
PubMed

Insights

Induced pluripotent stem cells (iPSCs) offer a powerful in vitro model for studying cardiovascular diseases. This technology advances disease modeling and drug testing, paving the way for future clinical research.

Area of Science:

  • Biomedical research
  • Stem cell technology
  • Cardiovascular medicine

Background:

  • Cardiovascular diseases (CVDs) pose a significant global health threat.
  • Understanding the pathogenesis of CVDs is crucial for effective treatment.
  • Existing knowledge of molecular pathways in CVDs lacks clear clinical significance.

Purpose of the Study:

  • To review the progress of induced pluripotent stem cells (iPSCs) in cardiovascular disease modeling.
  • To highlight the application of iPSCs in drug testing for cardiovascular conditions.
  • To discuss the technical advancements and clinical applications of iPSC technology.

Main Methods:

  • Literature review of iPSC applications in cardiovascular research.
  • Analysis of studies focusing on iPSC-based disease modeling.
  • Evaluation of iPSC use in preclinical drug screening.

Main Results:

  • iPSCs provide a patient-specific in vitro platform for modeling cardiovascular diseases.
  • iPSC technology enables the testing of potential drug candidates for cardiovascular therapies.
  • Significant technical advances have been made in iPSC generation and differentiation.

Conclusions:

  • iPSC technology is revolutionizing cardiovascular disease modeling and drug discovery.
  • Further research holds promise for translating iPSC applications into clinical practice.
  • iPSC-based approaches are poised to shape the future of translational cardiovascular research.
Keywords:
Cardiovascular diseasesDisease modelingDrug testingInduced pluripotent stem cells

More Related Videos

Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery12:40

Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery

Published on: May 19, 2018

10.7K
Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair06:37

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

8.8K

Related Concept Videos

Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.1K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.6K
Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.6K
In Vitro Drug Dissolution: Compendial Testing Models I01:13

In Vitro Drug Dissolution: Compendial Testing Models I

Compendial dissolution methods are standardized procedures defined by pharmacopeias to evaluate the rate at which a drug dissolves in a specific medium. These methods ensure batch-to-batch consistency, enable quality control, and support the prediction of drug bioavailability. They are critical for both immediate and modified-release drug products.The apparatuses used for dissolution testing differ in their design and mechanical function, but all aim to simulate the physiological environment of...
296
In Vitro Drug Dissolution: Compendial Testing Models II01:09

In Vitro Drug Dissolution: Compendial Testing Models II

Various dissolution methods are utilized to assess a drug’s dissolution rate, including the flow-through cell, paddle-over-disk, cylinder, and reciprocating disk methods.The flow-through cell apparatus (USP (United States Pharmacopeia) method 4) comprises a reservoir for the dissolution medium and a pump that propels the medium through the cell containing the test sample. This method is crucial for assessing modified-release dosage forms with minimally soluble active ingredients,...
336
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.3K